Cosmos Holdings Inc. Share Price OTC Markets
Stocks
COSM
US2214131078
Pharmaceuticals
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.510 USD | -5.65% |
|
-2.45% | - |
| Market Cap | 1.27Cr 1.1Cr 1.02Cr 93.64L 1.76Cr 120.76Cr 1.79Cr 12Cr 4.71Cr 60Cr 4.75Cr 4.65Cr 201.21Cr | P/E 2026 * |
23.3x | P/E 2027 * | 3.33x |
|---|---|---|---|---|---|
| Enterprise Value | 1.27Cr 1.1Cr 1.02Cr 93.64L 1.76Cr 120.76Cr 1.79Cr 12Cr 4.71Cr 60Cr 4.75Cr 4.65Cr 201.21Cr | EV / Sales 2026 * |
0.15x | EV / Sales 2027 * | 0.11x |
| Free-Float |
63.51% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -5.65% |
| Manager | Title | Age | Since |
|---|---|---|---|
Grigorios Siokas
CEO | Chief Executive Officer | 60 | 26/02/2016 |
Georgios Terzis
DFI | Director of Finance/CFO | 43 | 11/11/2020 |
| Chief Operating Officer | 56 | 01/02/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 58 | 13/01/2014 | |
Grigorios Siokas
CHM | Chairman | 60 | 26/02/2016 |
John Hoidas
BRD | Director/Board Member | 59 | 18/11/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -5.65% | -2.45% | - | - | 1.27Cr | ||
| +1.45% | +7.11% | +31.69% | +104.15% | 10TCr | ||
| +0.34% | +0.20% | +49.74% | +155.66% | 5.54TCr | ||
| -0.67% | +0.68% | +3.50% | +274.68% | 2.42TCr | ||
| +0.12% | -0.83% | -12.37% | -13.90% | 829.29Cr | ||
| +2.21% | +1.79% | -30.23% | -26.46% | 753.35Cr | ||
| +0.59% | -1.84% | -9.64% | -21.74% | 674.62Cr | ||
| 0.00% | +3.07% | +19.07% | +14.99% | 618.62Cr | ||
| 0.00% | -2.78% | -4.03% | +21.42% | 507.01Cr | ||
| +1.20% | -1.94% | -5.61% | -6.75% | 368.7Cr | ||
| Average | -0.10% | +0.38% | +4.68% | +55.78% | 2.43TCr | |
| Weighted average by Cap. | +0.88% | +1.56% | +26.24% | +116.91% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.43Cr 7.3Cr 6.82Cr 6.23Cr 12Cr 804Cr 12Cr 80Cr 31Cr 402.22Cr 32Cr 31Cr 1.34TCr | 11Cr 9.59Cr 8.97Cr 8.19Cr 15Cr 1.06TCr 16Cr 105.13Cr 41Cr 528.66Cr 42Cr 41Cr 1.76TCr |
| Net income | - | - |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COSM Stock
- COSM Stock
Select your edition
All financial news and data tailored to specific country editions
















